Henderson Jeffrey William (CIK 1324015) reported 17 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-05-07). Recent activity: Buy HALO (3,796 shares), Buy QCOM (2,563 shares), Buy QCOM (2,355 shares), Sell QCOM (759 shares), Buy BDX (1,098 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-07 | HALOZYME THERAPEUTICS, INC. (HALO) | Director | Buy | 3,796 | $0 |
| 2026-03-18 | QUALCOMM INC/DE (QCOM) | Director | Buy | 2,563 | $0 |
| 2026-03-09 | QUALCOMM INC/DE (QCOM) | Director | Buy | 2,355 | $0 |
| 2026-03-09 | QUALCOMM INC/DE (QCOM) | Director | Sell | 759 | $102,989 |
| 2026-01-29 | BECTON DICKINSON & CO (BDX) | Director | Buy | 1,098 | $0 |
| 2025-05-02 | HALOZYME THERAPEUTICS, INC. (HALO) | Director | Buy | 4,165 | $0 |
| 2025-04-28 | HALOZYME THERAPEUTICS, INC. (HALO) | Director | Sell | 4,297 | $259,281 |
| 2025-04-28 | HALOZYME THERAPEUTICS, INC. (HALO) | Director | Sell | 200 | $12,200 |
| 2025-04-01 | HALOZYME THERAPEUTICS, INC. (HALO) | Director | Sell | 503 | $32,217 |
| 2025-03-20 | QUALCOMM INC/DE (QCOM) | Director | Buy | 2,097 | $0 |
| 2025-03-10 | QUALCOMM INC/DE (QCOM) | Director | Buy | 1,901 | $0 |
| 2025-03-03 | HALOZYME THERAPEUTICS, INC. (HALO) | Director | Sell | 1,795 | $103,984 |
| 2025-03-03 | HALOZYME THERAPEUTICS, INC. (HALO) | Director | Sell | 3,205 | $189,480 |
| 2025-02-10 | BECTON DICKINSON & CO (BDX) | Director | Buy | 1,500 | $350,430 |
| 2025-02-04 | HALOZYME THERAPEUTICS, INC. (HALO) | Director | Sell | 1,100 | $61,534 |
| 2025-02-04 | HALOZYME THERAPEUTICS, INC. (HALO) | Director | Sell | 3,900 | $219,999 |
| 2025-01-30 | BECTON DICKINSON & CO (BDX) | Director | Buy | 930 | $0 |
Source: SEC Form 4 filings · as of 2026-05-07